Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × NETWORK × peginterferon alfa-2b × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

OTHER 2 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Radiotherapy 120 Cyclophosphamide 96 Cisplatin 93 Doxorubicin 86 Vincristine 67 Filgrastim 53 Etoposide 51 Paclitaxel 49 Carboplatin 48 Fluorouracil 45 Methotrexate 42 Dexamethasone 41 Prednisone 37 Cytarabine 36 Leucovorin 32 Granulocyte Colony-Stimulating Factor 30 Docetaxel 29 Radiation 27 Ifosfamide 24 Daunorubicin 23 Specimen Handling 22 Calcium Dobesilate 22 Tamoxifen 21 Platinum 20 Mercaptopurine 20 Gemcitabine 20 Chemotherapy, Adjuvant 20 1,2-diaminocyclohexaneplatinum II citrate 20 Magnetic Resonance Spectroscopy 19 Goserelin 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00134030 2023-06-07

EURAMOS-1

Children's Oncology Group

Phase 3 Completed

1,334 enrolled 17 charts

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡